Rocket


News + Filings
Transactions


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Hohl Benjamin Create: Alert

All | News | Filings
Date FiledTypeDescription
02/27/2023 4 Hohl Benjamin (CFO) has filed a Form 4 on Enliven Therapeutics, Inc.
Txns: Granted 262,120 options to buy @ $2.48, valued at $650.1k
02/27/2023 3 Hohl Benjamin (CFO) has filed a Form 3 on Enliven Therapeutics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy